echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > How viruses turn immune cells into cancer

    How viruses turn immune cells into cancer

    • Last Update: 2021-12-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    An international research team mapped how the HTLV-1 virus causes a rare leukemia in some people, providing clues on how to prevent the occurrence of this disease


    A research team led by Imperial College London and Kumamoto University in Japan used single-cell analysis to reveal how the virus over-activated T cells (key immune cells in our blood), causing them Cancerous


    This rare cancer is called adult T-cell leukemia/lymphoma (ATL).


    ATL can progress slowly or positively, but there is no standard treatment for high-grade ATL, and the recurrence rate is high after chemotherapy and antiviral drugs


    The results of the research team published today in the "Journal of Clinical Investigation" showed that the virus hijacked the activation mechanism of T cells, causing them to continue to be activated at a high level and gradually become malignant


    Professor Yorifumi Satou, the co-lead researcher from Kumamoto University, is a virologist who studies HTLV-1


    Co-Principal Investigator Dr.


    Leukemia is a cancer that originates in blood or bone marrow cells and is characterized by a large increase in the number of abnormal white blood cells


    The HTLV-1 virus inserts itself into a type of T cell, and, first of all, remains in a "latent" state there, without releasing any new virus particles or causing any adverse effects


    The research team studied more than 87,000 T cells from virus-free donors, healthy virus carriers, and ATL patients


    They found that in patients who progressed to ATL, HTLV-1 makes infected T cells highly active and overreacting, causing them to overproduce protein, keeping them proliferating, and helping them avoid the immune system that normally clears bad cells.


    The research team believes that these changes make overactive T cells more susceptible to DNA damage, such as chemicals or radiation, and accelerate their transition to a cancerous state


    The authors say that further research on related processes will lay the foundation for potential new treatment options


    references:

    "HTLV-1 infection promotes excessive T cell activation and transformation into adult T cell leukemia/ lymphoma" 15 December 2021, Journal of Clinical Investigation.


    DOI: 10.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.